liljasol

The window to submit your abstract for WMIC 2026 is closing fast. Submit your work and join us this September in Salt Lake City. Abstract deadline: Friday, April 17, 2026 🔗 wmis.org/wmic-2026/abst… #WMIC2026 #MolecularImaging #SLC

ONE WEEK TO GO! This is your final Friday to finalize those abstracts. Join us in SLC for the premiere event in molecular imaging. Portal closes April 17. wmis.org/wmic-2026/abst… #WMIC2026 #SLC #molecularImaging

📢 Deadline Extended! Nominate outstanding women for WIMIN Awards at #WMIC2025 by Aug 8. Celebrate leaders, innovators, and rising stars in molecular imaging! 🌟✨ Submit now: ow.ly/et4H50WkHaz #WIMIN #WomenInSTEM #MolecularImaging

Continuing education: Treatment response evaluation in prostate cancer using PSMA PET/CT. ow.ly/uUgP50WocwV #NuclearMedicine #RPTherapy #ProstateCancer @liljasolnes @FrancescoCeci13 @DrAGafita

Evidence-based clinical protocols to monitor efficacy of ¹⁷⁷Lu-PSMA #RPTherapy in metastatic castration-resistant #ProstateCancer using real-world data. ow.ly/7K8n50VKMaB #NuclearMedicine @DrAGafita @liljasolnes @UnterrainerLena @MUnterrainerMD

pubmed.ncbi.nlm.nih.gov/40473460/ Excellent evaluation of #PSMA #PET #molecularimaging for response assessment in #prostatecancer from @DrAGafita @liljasolnes @Hopkins_Rad @UNCRadiology

Diagnostic radiopharmaceuticals: A sustainable path to the improvement of patient care. ow.ly/eNSm50UUxIk #MolecularImaging #Theranostics #NuclearMedicine @liljasolnes @DrAGafita

Renal function has no detectable affect on renal mass sestamibi uptake pubmed.ncbi.nlm.nih.gov/39876805/ @michael_gorin @liljasolnes @AlirezaAmin10 @nirmishsingla

Diagnostic radiopharmaceuticals: A sustainable path to the improvement of patient care. ow.ly/y69v50TKWtx #NuclearMedicine #MedicalImaging @liljasolnes @DrAGafita

Mark your calendars for #WMIC2025! 📅 September 29 - October 3, 2025 📍 Anchorage, Alaska, USA Join the global community for cutting-edge discussions in a unique natural setting that inspires creativity. Stay tuned for updates on abstracts, registration, and exciting events!

Initial Experience with [177Lu]Lu-PSMA-617 After Regulatory Approval for Metastatic Castration-Resistant Prostate Cancer: Efficacy, Safety, and Outcome Prediction out on Journal of Nuclear Medicine☢️ jnm.snmjournals.org/content/early/… The study investigated the real-world efficacy and safety of [177Lu]Lu-PSMA-617, approved for treating prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant #ProstateCancer (mCRPC), at Johns Hopkins Hospital🇺🇸. Among 76 patients receiving the treatment, a prostate-specific antigen (PSA) response of at least 50% was achieved in 41% of cases, with median PSA progression-free survival (PFS) of 4.1 months and overall survival (OS) of 13.7 months. Notable adverse effects included grade 3 anemia in 12% and transient xerostomia in 28%. The presence of aggressive-variant prostate cancer genes correlated with shorter PSA PFS. Additionally, artificial intelligence analysis of baseline PSMA PET/CT images identified responders more accurately, suggesting that this approach could enhance patient selection. The findings indicate promising antitumor activity and a favorable safety profile for [177Lu]Lu-PSMA-617, warranting further validation in larger cohorts. @hopkinskimmel @AveryS32342 @MarkowskiGUOnc @Cpaller @liljasolnes

Congratulations to Dr. Peter Caravan on receiving our highest honor, the prestigious Gold Medal Award at #WMIC2024! 🏅 Join us in celebrating this exceptional achievement! #MolecularImaging #ResearchExcellence #WMIS

Extremely proud of our latest work on renal masses: a nuanced look at #sestamibi #molecularimaging in chromophobe #RCC. Particular great work from Dr. Salikh Murtazaliev @uarizona. @liljasolnes @UNCRadiology @allaf_mo @michael_gorin @gottsled pubmed.ncbi.nlm.nih.gov/39078524/

Check out our latest review on #renalmass molecular imaging. More from us soon on this exciting topic! #sestamibi #girentuximab @liljasolnes @michael_gorin @UNCRadiology @gottsled pubmed.ncbi.nlm.nih.gov/39054210/

GI transit scintigraphic exams play a central role in diagnosis & treatment of GI disorders & are developed for use in evaluating small & large bowel transit. Let’s learn more from Banks and team! 1/7 bit.ly/45jMgq4 #RGphx #NucMed @Radiographics @elojeimy

New @AJR_Radiology Accepted Manuscript: "Beyond the AJR: Improving Screening Rates With Bulk Mammogram Orders and Text Messages" By Drs Woodard & Yalniz @UABRadiology ajronline.org/doi/10.2214/AJ…

🎉 A big thank you to our incredible WMIC community for your amazing late-breaking abstracts! Your cutting-edge research drives our field forward. Didn't submit? No worries! There's still plenty to enjoy at #WMIC2024. We'll see you in Montreal for an unforgettable conference!

🌟 Celebrating International Women in Engineering Day! 🚀 From groundbreaking innovations to shaping the future of healthcare and technology, women engineers lead the way! 💪 #INWED #WomenInEngineering #MolecularImaging #WMIS #WIMIN

Due to popular demand, the abstract submission deadline for #WMIC2024 has been extended! The NEW late-breaking abstract submission deadline is: Friday, June 21st, 2024 at 11:59 PM PDT Start preparing your abstracts now! More details at wmis.org/abstract-categ…

Congratulations to our fantastic team at Johns Hopkins Theranostics Center for being recognized by @SNM_MI a Therapy Center of Excellence! @liljasolnes @AveryS32342 @daniellerill Jeffrey Young @Hopkins_Rad